Home  >  Products  >  KDR (kinase insert domain receptor (a type III receptor tyrosine kinase)) Blocking Peptide (the N terminal of protein) (100ug)
KDR (kinase insert domain receptor (a type III receptor tyrosine kinase)) Blocking Peptide (the N terminal of protein) (100ug)

KDR (kinase insert domain receptor (a type III receptor tyrosine kinase)) Blocking Peptide (the N terminal of protein) (100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-KDR antibody (Catalogue #: AVARP20010_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Presku: AAP30576
Size: 100 ug
Weight: 151kDa
Gene: 3791
Format: Lyophilized powder
Target: KDR is the receptor for VEGF or VEGFC. It has a tyrosine-protein kinase activity. The VEGF-kinase ligand/receptor signaling system plays a key role in vascular development and regulation of vascular permeability. In case of HIV-1 infection, the interaction with extracellular viral Tat protein seems to enhance angiogenesis in Kaposi's sarcoma lesions.
Alternative names: CD309; FLK1; VEGFR; VEGFR2
See Full Product Listings >